
Citation From the August 29, 2023, edition of Westwood One's The Mark Levin Show MARK LEVIN (HOST): Contrary to how it's been framed, the Inflation Reduction Act's drug pricing program doesn't involve negotiated – negotiation in any ordinary sense of the word. If a drug developer disagrees with the dictate price, our only options are to pay impossibly high penalties or withdraw all our medicines from Medicare and Medicaid altogether. That's not a choice. We'd never do that to our patients. So that essentially lets the government set any price...